(Q48313359)

10 February 2018

title

Reliability and validity of the psoriasis symptom inventory in patients with moderate-to-severe psoriasis (English)

1 reference

10 February 2018

1

Dennis A Revicki

1 reference

10 February 2018

author name string

Ying Jin

2

1 reference

10 February 2018

Hilary D Wilson

3

1 reference

10 February 2018

Dina Chau

4

1 reference

10 February 2018

Hema N Viswanathan

5

1 reference

10 February 2018

publication date

11 June 2013

1 reference

10 February 2018

Journal of Dermatological Treatment

published in

1 reference

10 February 2018

volume

25

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

page(s)

8-14

1 reference

10 February 2018

Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment.

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2013.769042

The impact of psoriasis on quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2013.769042

The burden of psoriasis is not determined by disease severity only.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2013.769042

Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2013.769042

Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: patient-reported outcomes from a phase II randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2013.769042

The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2013.769042

Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2013.769042

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2013.769042

Coefficient alpha and the internal structure of tests

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2013.769042

Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2013.769042

10.3109/09546634.2013.769042

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018